Gp130 Signaling in NOD2-Driven Crohn's Disease: A Key Player in Fibrosis and a Novel Target for Refractory Patients.

Bustos, Matilde; Carneros, David; Giraldez, Maria D.

Afiliação

Bustos M; Institute of Biomedicine of Seville (IBiS), Spanish National Research Council (CSIC), University of Seville, Virgen del Rocio University Hospital, Seville, Spain.
Carneros D; Institute of Biomedicine of Seville (IBiS), Spanish National Research Council (CSIC), University of Seville, Virgen del Rocio University Hospital, Seville, Spain.
Giraldez MD; Institute of Biomedicine of Seville (IBiS), Spanish National Research Council (CSIC), University of Seville, Virgen del Rocio University Hospital, Seville, Spain.

Gastroenterology ; 161(3): 1063-1065, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34146574

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article